Browsing Category

65311 posts
The Inaugural One Earth Summit Closes with Call for Global Public-Private-Philanthropic Partnerships for Effective Climate Action

The Inaugural One Earth Summit Closes with Call for Global Public-Private-Philanthropic Partnerships for Effective Climate Action

Over 1,000 influential leaders and changemakers gathered in Hong Kong at the…
Be Friends Holding Limited announces FY2023 financial results: annual GMV exceeded RMB12 billion, revenue increased by approximately 152% YoY, and adjusted net profit surged by approximately 601% YoY

Be Friends Holding Limited announces FY2023 financial results: annual GMV exceeded RMB12 billion, revenue increased by approximately 152% YoY, and adjusted net profit surged by approximately 601% YoY

HONG KONG, March 26, 2024 /PRNewswire/ — Be Friends Holding Limited (together…
Let the Games Begin at the 2024 Rolex China Sea Race

Let the Games Begin at the 2024 Rolex China Sea Race

HONG KONG, March 26, 2024 /PRNewswire/ — The stage is set for…
Unilumin's Original LED Display Products Won Four iF Design Awards

Unilumin's Original LED Display Products Won Four iF Design Awards

The iF Design Award is highly regarded as an authoritative award worldwide…
A New Epoch in Fashion: Nanshan's Collaboration with Milan Redefines the Buying Landscape

A New Epoch in Fashion: Nanshan's Collaboration with Milan Redefines the Buying Landscape

SHENZHEN, China, March 26, 2024 /PRNewswire/ – The Shenzhen-Milan Lifestyle Week launched on…
Keystone Education Group acquires Asia Exchange and Edunation

Keystone Education Group acquires Asia Exchange and Edunation

NEW STUDY PATHWAYS TO ASIA, EUROPE, AND LATIN AMERICA OSLO, Norway and…
Whiskas creates new breed of dog

Whiskas creates new breed of dog

AUCKLAND, New Zealand, March 26, 2024 /PRNewswire/ — The world loves dogs.…
Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa

Nanoscope Therapeutics Announces Positive Top-line Results from Randomized Controlled Trial of MCO-010 for Retinitis Pigmentosa

MCO-010 achieved its primary and key secondary endpoints with statistical significance and…